Skip to main content
Clinical Trials/NCT03642652
NCT03642652
Completed
Not Applicable

Repeated Automated Mobile Text Reminders for Follow-up of Positive Fecal Occult Blood Tests: a Randomized Controlled Trial

Meuhedet. Healthcare Organization0 sites470 target enrollmentApril 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Meuhedet. Healthcare Organization
Enrollment
470
Primary Endpoint
Follow-up colonoscopy 120 days after a positive fecal occult blood test
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

A randomized controlled trial to examine the effect of 3 mobile telephone text message reminders on followup colonoscopy 120 days after a positive fecal occult blood test among Meuhedet members aged 50-74 who tested positive in 2016.

Detailed Description

Background: Fecal occult blood tests are recommended by the US Preventive Services Task Force as a screening method for colorectal cancer, but they are only effective if positive results are followed by colonoscopy. Surprisingly, a large proportion of patients with a positive result do not follow this recommendation. Objective: To examine the effectiveness of a short message service in increasing adherence to colonoscopy follow-up after a positive fecal occult blood test. Methods: This randomized controlled trial was conducted with patients who had positive colorectal cancer screening results. Randomization was stratified by residential district and socioeconomic status. Subjects in the control group (n = 238) received routine care that included an alert to the physician regarding the positive Fecal occult blood test result. The intervention group (n = 232) received routine care and three short message service reminders to visit their primary care physician. Adherence to colonoscopy was measured 120 days from the positive result. All patient information, including test results and colonoscopy completion, were obtained from their computerized medical records. Physicians of the study patients completed an attitude survey regarding FOBT as a screening test for colorectal cancer. The intervention and control groups were compared using chi-squared for discrete variables. Logistic regression was used to calculate odds ratios and 95% confidence intervals for performing colonoscopy within 120 days, adjusting for potential confounders of age, gender, socioeconomic status, district, ethnicity, intervention group and physician's attitude.

Registry
clinicaltrials.gov
Start Date
April 1, 2016
End Date
May 1, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel

Investigators

Sponsor
Meuhedet. Healthcare Organization
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • positive fecal occult blood test (FOBT) in 2016
  • agreed to receive SMS from healthcare provider

Exclusion Criteria

  • Existing oncology diagnosis
  • personal or family history of colorectal cancer
  • colonoscopy up to 10 years prior to FOBT

Outcomes

Primary Outcomes

Follow-up colonoscopy 120 days after a positive fecal occult blood test

Time Frame: 120 days after positive FOBT

Completion of colonoscopy

Similar Trials